drugset
drugset / Trial / NCT02117141

To Assess the Rate and Extent of Absorption of Hydrocodone From 20 mg Hydrocodone Bitartrate Extended-Release Capsules

NCT02117141 ↗

Phase 1 Completed 12 enrolled Zogenix, Inc.
Non-randomizedSingle-groupOpen-labelOther

Summary

* Assess the rate and extent of absorption of hydrocodone from a 20 mg HC-ER capsule in both fed and fasted states * Evaluate the safety and tolerability of the test compound administered orally

Timeline

Start
2002-06
Primary completion
2002-06
Completion
2002-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydrocodone Unknown 20 mg Oral

Indications

No indication recorded.